About the Authors
- Amy P. Abernethy
-
* E-mail: amy@flatiron.com
Affiliations Flatiron Health, Inc., New York, New York, United States of America, Duke University School of Medicine, Durham, North Carolina, United States of America
- Ashwini Arunachalam
-
Affiliation Center for Observational & Real World Evidence (CORE), Merck & Co., Inc., Kenilworth, New Jersey, United States of America
- Thomas Burke
-
Affiliation Center for Observational & Real World Evidence (CORE), Merck & Co., Inc., Kenilworth, New Jersey, United States of America
- Caroline McKay
-
Affiliation Center for Observational & Real World Evidence (CORE), Merck & Co., Inc., Kenilworth, New Jersey, United States of America
- Xiting Cao
-
Affiliation Center for Observational & Real World Evidence (CORE), Merck & Co., Inc., Kenilworth, New Jersey, United States of America
- Rachael Sorg
-
Affiliation Flatiron Health, Inc., New York, New York, United States of America
- David P. Carbone
-
Affiliation James Thoracic Oncology Center, Medical Oncology, The Ohio State University, Columbus, Ohio, United States of America
Competing Interests
Amy Abernethy and Rachael Sorg are salaried by Flatiron Health. Caroline McKay, Thomas Burke, and Xiting Cao are salaried by Merck & Co. Ashwini Arunachalam is an Oncology Outcomes Research Fellow at Merck. David Carbone reports grant/research support from Bristol Myers-Squibb and honoraria/consulting fees from Bayer Health Care, Biothera, Boehringer Ingelheim, Cancer Support Community, Celgene, Clovis Oncology, Genentech/Roche, Genoptix, GlaxoSmithKline, ImmuneDesign, Janssen Diagnostics, MedImmune, Merck, Novartis, Pfizer, Synta Pharmaceuticals Corp, and Verastem. There are no products in development, patents, or marketed products to declare in relation to this study's conclusions. These affiliations do not alter our adherence to PLOS ONE policies on sharing data and materials.
Author Contributions
Conceptualization: AA APA TB CM XC RS DC. Data curation: XC APA. Formal analysis: XC. Funding acquisition: TB. Investigation: APA. Methodology: AA APA TB CM XC DC. Project administration: AA TB CM. Resources: CM. Software: XC APA. Supervision: TB APA. Validation: AA TB CM XC RS DC. Visualization: AA TB CM XC RS DC. Writing – original draft: AA TB CM XC RS DC. Writing – review & editing: AA TB CM XC RS DC.